Fluofarma is a privately-held contract service provider which offers High
Content Screening (HCS) services for target and drug discovery, predictive
toxicity testing and cosmetics development.
Breaking news
Scientific Publication
Fluofarma is glad to announce a new scientific publication in the journal Cell Research.Read more [+]
Publication
Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”Read more [+]
Press Release
Roche adopts Fluofarma’s high-content screening platform.Read more [+]
Scientific Publication
Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".Read more [+]